Specifications - ImClone Systems Biopharmaceutical Plant, Branchburg, NJ, USA

Key Data
Order year	2004
Project type	Plant expansion
Location	Branchburg, New Jersey, USA
Estimated investment	$260 million
Completion	2006
Key Players
Sponsor	ImClone Systems, Inc.
Lead contractor	Kvaerner, Binskey and Snyder, Vicataulic, Midwest Mechanical Contractors
Output Chemicals
Cancer therapeutic	Erbitux commercially and other pipeline drugs for investigational quantities
Featured Suppliers
Applikon Biotechnology - Bioreactor Systems
AQUA-NOVA Elander Systems AB - WFI Water Stills and Pure Steam Generators
Doctor Furnace - Environmental, Cold, Explosion and Clean Rooms